Delivery Order SPE2DB22D1106-SPE2DB24FECD2
- Not listed
- This federal contract award is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,741.62 award is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a pharmaceutical product. The order has a completion date of February 28, 2024 and was awarded on February 27, 2024. This delivery order...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $7,118.58 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. This order is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a diabetes medication. The delivery order has a completion date of February 6, 2024 and was awarded on February 5, 2024. This award is part of Amerisourcebergen Drug Corp's broader indefinite delivery contract (IDC) with...
- This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $3,652.65 firm-fixed price contract is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The award has an ultimate completion date of April 18, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The award, valued at $4,157.24, is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml to support military treatment programs and facilities. The delivery order has a performance period ending on March 27, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order (SPE2DB22D1017|SPE2DB24FF4HW) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The award has a completion date of March 18, 2024 and a ceiling value of $2,679.83. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is not part of a set-aside program. This award is associated with a larger...
- The Defense Logistics Agency (DLA) awarded a $3,287.16 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml pharmaceutical product. The contract has an ultimate completion date of May 15, 2024. Amerisourcebergen Drug Corp holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, the prime contractor, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The award, valued at $6,076.67, has an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corporation is a for-profit organization and a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The award has a ceiling value of $5,224.86 and a period of performance through March 29, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA, valued at up to $999,999,999.00 through December 31, 2025, which...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,932.90 firm fixed-price award is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a diabetes medication. The contract has a period of performance through February 25, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $45,044.88 firm fixed-price contract is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a diabetes medication. The award has a completion date of February 12, 2025 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FECD2Delivery Order
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $1,129.08 award is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The delivery order has a completion date of February 28, 2024 and was awarded on February 27, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific award is not designated as a set-aside contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 2/27/24 |